CABG versus PCI in multilesional vessel disease

Yi Chih Wang, Juey Jen Hwang, Jiunn-Lee Lin

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

With numerous trials conducted during the 1970s and 1980s evaluating coronary artery bypass surgery (CABG) versus medical treatment for patients with coronary artery disease (CAD), the absolute benefi t of surgery was shown to be prominent especially for those with more extensive coronary involvement. However, the pronounced effect of CABG for patients with multivessel CAD (MVD) has faced continuing challenges since the introduction of percutaneous coronary intervention (PCI) and evolving revascularization technology, such as coronary stents.

Original languageEnglish
Title of host publicationCoronary Graft Failure
Subtitle of host publicationState of the Art
PublisherSpringer International Publishing
Pages161-165
Number of pages5
ISBN (Electronic)9783319265155
ISBN (Print)9783319265131
DOIs
Publication statusPublished - Jan 1 2016
Externally publishedYes

Keywords

  • Bare metal stent (BMS)
  • Coronary artery bypass surgery (CABG)
  • Coronary artery disease (CAD)
  • Drugeluting stent (DES)
  • Multivessel disease (MVD)
  • Percutaneous coronary intervention (PCI)
  • Percutaneous transluminal coronary angioplasty (PTCA)
  • Revascularization

ASJC Scopus subject areas

  • Medicine(all)

Fingerprint Dive into the research topics of 'CABG versus PCI in multilesional vessel disease'. Together they form a unique fingerprint.

  • Cite this

    Wang, Y. C., Hwang, J. J., & Lin, J-L. (2016). CABG versus PCI in multilesional vessel disease. In Coronary Graft Failure: State of the Art (pp. 161-165). Springer International Publishing. https://doi.org/10.1007/978-3-319-26515-5_15